Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Original Breeders League (OBL) is an agricultural biotechnology company specializing in the genetic stabilization and optimization of cannabis and hemp cultivars. The company focuses on preserving rare landrace genetics while utilizing modern genomic tools to develop high-performance chemotypes for pharmaceutical and therapeutic applications. OBL provides specialized breeding services, genetic IP licensing, and high-quality starting materials for the global medical cannabis industry. Their work bridges the gap between traditional botanical knowledge and contemporary molecular biology to ensure chemical consistency in plant-based medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Original Breeders League.